AHCP Blog | Legislation

Prior Authorization in Medicare Advantage

Published: January 9, 2026

Prior authorization has long been part of the Medicare Advantage (MA) landscape, but over the past few years it has moved from a background administrative issue to a front-and-center policy debate – both inside Washington and well beyond it.

Read

What the Big Beautiful Bill Did (and Did Not Do) for HSAs

Published: September 18, 2025

You and your clients may have heard and been excited about several proposed HSA enhancements in the One Big Beautiful Bill Act (OBBB). Unfortunately, not all of them made the cut. So we thought we’d share some quick info to let you know what actually made it into law, what didn’t pass, and why it matters.

Read

Insulin Price Cap: A Step Forward for People with Diabetes

Published: April 28, 2023

There’s been a LOT of information in the news recently about the cost of insulin. And while this is obviously important and of interest to your diabetic clients, it can be difficult to keep it all straight – what changes have merely been proposed and which ones have actually passed? As agents, it’s important to stay informed about these changes so we can answer our clients’ questions and let them know what to expect.

Read

Medical Debt Remains a Big Issue for Consumers

Published: September 2, 2022

In 2019, the American Journal of Public Health published the results of an analysis about bankruptcies in the United States and concluded that medical bankruptcy is still common despite the Affordable Care Act: “Despite gains in coverage and access to care from the ACA, our findings suggest that it did not change the proportion of bankruptcies with medical causes.”

Read

Will Congress Extend the Enhanced Premium Tax Credits?

Published: August 26, 2022

A huge question right now—one that will have a big impact on insurance agents and their clients this fall—is whether Congress will extend the enhanced premium tax credits that have been in place for the last two years.

Read

Senate Passes Bill to Extend Subsidies, Lower Drug Costs

Published: August 17, 2022

After a lengthy debate, and without a single Republican vote, Democrats in the Senate passed the Inflation Reduction Act, a $430 billion bill that will, among other things, extend the enhanced premium tax credits and lower drug costs.

Read

CHIP FINALLY Gets Reauthorized

Published: March 5, 2018

The Children’s Health Insurance Program, or CHIP, has been in the news recently as lawmakers debate the future of this popular safety net program for children of lower-income families. The program, which has been around since 1997, has enjoyed nearly universal bipartisan support from the beginning, but that support has come into question recently as Congress allowed funding for CHIP to expire four months ago and seemed to be in no hurry to reauthorize it. As worried parents waited to see what our lawmakers would do, CHIP reauthorization took a back seat to tax reform.

Read

Join Our Newsletter